Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1970 May;49(5):1007–1015. doi: 10.1172/JCI106300

Effects of hyperlipoproteinemias and their treatment on the peripheral circulation

Robert Zelis 1, Dean T Mason 1, Eugene Braunwald 1, Robert I Levy 1
PMCID: PMC535752  PMID: 5441536

Abstract

The purpose of this study was to determine the effect of familial hyperlipoproteinemia (HLP) on peripheral vascular disease (PVD) and the extent to which the vascular disease (PVD) and the extent to which the vascular disease is modified by treatment of the lipoprotein disorder. PVD was detected plethysmographically by observing a diminished peak reactive hyperemia blood (PRHBF) following ischemia. The value for PRHBF in the extremity demonstrating the lowest response in 32 normal subjects (age 19-50 yr) was 39.6±1.5 SEM, ml/min per 100 g. Patients with untreated HLP. who had PRHBF below the lower limit of normal, were 2 of 11 type II, 9 of 12 type III, 1 of 10 type IV. As a group, patients with type III HLP showed diminished PRHBF (26.6 ±3.0 ml/min per 100 g, P <0.01). In view of the high incidence of PVD and the striking reduction in serum lipids and complete resorption of xanthomas observed in type III HLP with therapy, six patients were studied before and after 3-6 months of treatment with a therapeutic diet and clofibrate. PRHBF in the most severely affected extremity increased markedly, from 20.4 ±1.6 to 31.9 ±1.8 ml/min per 100 g (P<0.01), indicating a dramatic increase in maximum blood flow to this extremity. In two type III patients with PVD not treated, no change in PRHBF occurred over 5 months. In two other type III patients the PRHBF increased 17% during the first 25 days of therapy concomitant with a 30% reduction in whole blood viscosity. Over the next 120 days, blood viscosity decreased only an additional 4.6% whereas the PRHBF increased 57%, indicating that the observed changes seen in the PRHBF with therapy of type III patients can be only minimally accounted for by changes in the viscosity of the blood. Thus, patients with type III HLP are particularly susceptible to the development of PVD and objective improvement of PVD can occur with medical treatment of this lipid transport disorder.

Full text

PDF
1007

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRINK M. J. Triglycerides, lipoproteins, and coronary artery disease. Arch Intern Med. 1962 Mar;109:345–359. doi: 10.1001/archinte.1962.03620150095013. [DOI] [PubMed] [Google Scholar]
  2. CONWAY J. A vascular abnormality in hypertension. A study of blood flow in the forearm. Circulation. 1963 Apr;27(4 Pt 1):520–529. doi: 10.1161/01.cir.27.4.520. [DOI] [PubMed] [Google Scholar]
  3. Dayton S., Pearce M. L., Goldman H., Harnish A., Plotkin D., Shickman M., Winfield M., Zager A., Dixon W. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet. 1968 Nov 16;2(7577):1060–1062. doi: 10.1016/s0140-6736(68)91531-6. [DOI] [PubMed] [Google Scholar]
  4. Epstein F. H. The epidemiology of coronary heart disease. A review. J Chronic Dis. 1965 Aug;18(8):735–774. doi: 10.1016/0021-9681(65)90017-2. [DOI] [PubMed] [Google Scholar]
  5. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 19;276(3):148–contd. doi: 10.1056/NEJM196701192760305. [DOI] [PubMed] [Google Scholar]
  6. HOLLING H. E., BOLAND H. C., RUSS E. Investigation of arterial obstruction using a mercury-in-rubber strain gauge. Am Heart J. 1961 Aug;62:194–205. doi: 10.1016/0002-8703(61)90318-0. [DOI] [PubMed] [Google Scholar]
  7. Heinle R. A., Levy R. I., Frederickson D. S., Gorlin R. Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease. Am J Cardiol. 1969 Aug;24(2):178–186. doi: 10.1016/0002-9149(69)90401-9. [DOI] [PubMed] [Google Scholar]
  8. JONES H. B., GOFMAN J. W., LINDGREN F. T., LYON T. P., GRAHAM D. M., STRISOWER B., NICHOLS A. V. Lipoproteins in atherosclerosis. Am J Med. 1951 Sep;11(3):358–380. doi: 10.1016/0002-9343(51)90171-4. [DOI] [PubMed] [Google Scholar]
  9. Kannel W. B., Castelli W. P., McNamara P. M. The coronary profile: 12-year follow-up in the Framingham study. J Occup Med. 1967 Dec;9(12):611–619. [PubMed] [Google Scholar]
  10. Kerslake D. M. The effect of the application of an arterial occlusion cuff to the wrist on the blood flow in the human forearm. J Physiol. 1949 Jun 15;108(4):451–457. doi: 10.1113/jphysiol.1949.sp004348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Levy R. I., Fredrickson D. S. Diagnosis and management of hyperlipoproteinemia. Am J Cardiol. 1968 Oct;22(4):576–583. doi: 10.1016/0002-9149(68)90165-3. [DOI] [PubMed] [Google Scholar]
  12. PATTERSON G. C., WHELAN R. F. Reactive hyperaemia in the human forearm. Clin Sci. 1955 May;14(2):197–211. [PubMed] [Google Scholar]
  13. WELLS R. E., Jr, MERRILL E. W. Shear rate dependence of the viscosity of whole bllod and plasma. Science. 1961 Mar 17;133(3455):763–764. doi: 10.1126/science.133.3455.763. [DOI] [PubMed] [Google Scholar]
  14. WELLS R. E., Jr, MERRILL E. W. The variability of blood viscosity. Am J Med. 1961 Oct;31:505–509. doi: 10.1016/0002-9343(61)90134-6. [DOI] [PubMed] [Google Scholar]
  15. WINSOR T. Simplified determination of arterial insufficiency; plethysmographic observation of reactive hyperemia following fifteen minute arterial occlusion at the ankle. Circulation. 1951 Jun;3(6):830–836. doi: 10.1161/01.cir.3.6.830. [DOI] [PubMed] [Google Scholar]
  16. WOOD J. E., LITTER J., WILKINS R. W. The mechanism of limb segment reactive hyperemia in man. Circ Res. 1955 Nov;3(6):581–587. doi: 10.1161/01.res.3.6.581. [DOI] [PubMed] [Google Scholar]
  17. Winsor T., Simmons E. M., Borhani N., Hechter H. H. A diagnostic aid for determining peripheral arteriosclerosis obliterans. Dis Chest. 1967 Oct;52(4):451–457. doi: 10.1378/chest.52.4.451. [DOI] [PubMed] [Google Scholar]
  18. Zelis R., Mason D. T., Barth W. Abnormal peripheral vascular dynamics in systemic amyloidosis. Ann Intern Med. 1969 Jun;70(6):1167–1172. doi: 10.7326/0003-4819-70-6-1167. [DOI] [PubMed] [Google Scholar]
  19. Zelis R., Mason D. T., Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest. 1968 Apr;47(4):960–970. doi: 10.1172/JCI105788. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES